Peptidylglycine alpha-amidating monooxygenase (PAM) is a bifunctional enzyme that catalyzes the C-terminal alpha-amidation of peptide hormones and neuropeptides, a post-translational modification essential for the bioactivity of over half of all known bioactive peptides. The enzyme contains two catalytic domains within a single polypeptide. The N-terminal PHM (peptidylglycine alpha-hydroxylating monooxygenase) domain performs the rate-limiting stereospecific hydroxylation of the C-terminal glycine residue, requiring two copper ions, molecular oxygen, and L-ascorbate as an electron donor. The C-terminal PAL (peptidyl-alpha-hydroxyglycine alpha-amidating lyase) domain then cleaves the hydroxylated intermediate to yield the alpha-amidated peptide product and glyoxylate. PAM is a type I transmembrane protein synthesized with an N-terminal signal peptide that directs it into the secretory pathway. It localizes to the trans-Golgi network and secretory granule membranes, where it processes glycine-extended peptide precursors into their mature amidated forms. Soluble PAM forms generated by endoproteolytic processing can be secreted into the extracellular space. Beyond catalysis, PAM plays a structural role in secretory granule biogenesis. Major substrates include vasopressin, oxytocin, neuropeptide Y, substance P, cholecystokinin, gastrin, calcitonin, adrenomedullin, and CGRP.
Summary: PAM is the sole enzyme responsible for C-terminal alpha-amidation of bioactive peptides, making this the primary biological process annotation for this gene. The ARBA-based IEA annotation is well-supported.
Reason: Peptide amidation is the defining biological process of PAM. The deep research confirms PAM is "the sole enzyme known to catalyze C-terminal alpha-amidation of peptides, a post-translational modification essential for the biological activity of over 70 bioactive peptides." The IEA evidence from ARBA is appropriate for this unreviewed TrEMBL entry and accurately reflects the core biological role.
PAM is the sole enzyme known to catalyze C-terminal Ξ±-amidation of peptides, a post-translational modification essential for the biological activity of over 70 bioactive peptides
Summary: This is an overly generic molecular function annotation. PAM has well-defined specific catalytic activities (peptidylglycine monooxygenase and peptidylamidoglycolate lyase) that are already annotated with more informative terms.
Reason: GO:0003824 (catalytic activity) is a root-level MF term that provides no information beyond what is already captured by the more specific annotations GO:0004504 (peptidylglycine monooxygenase activity), GO:0004598 (peptidylamidoglycolate lyase activity), and GO:0016715 (oxidoreductase activity with ascorbate as donor). The InterPro-based annotation from IPR000720 and IPR008977 domains correctly identifies PAM as catalytically active, but the specific activity terms are far more informative.
Summary: Monooxygenase activity is correct for the PHM domain of PAM but is less specific than the available term GO:0004504 (peptidylglycine monooxygenase activity), which is already annotated.
Reason: The PHM domain of PAM is indeed a monooxygenase, so this annotation is technically correct. However, GO:0004504 (peptidylglycine monooxygenase activity) is a child term of GO:0004497 and provides more precise functional information. The InterPro-based annotation from Cu2_ascorb_mOase domains (IPR000323, IPR036939) is appropriate but redundant with the more specific term. Retaining as non-core since the specific term is already present.
Summary: This is the specific molecular function of the PHM domain of PAM, representing the rate-limiting first step of the peptide amidation reaction. The annotation is strongly supported by EC number mapping and domain analysis.
Reason: GO:0004504 corresponds to EC 1.14.17.3, which is the precise enzymatic activity of the PHM domain. The UniProt entry explicitly lists this EC number. The annotation is derived from combined automated methods (GO_REF:0000120) using EC:1.14.17.3 and PANTHER family assignment, both of which correctly identify this as a peptidylglycine monooxygenase. This is a core molecular function of PAM.
The N-terminal PHM domain catalyzes the stereospecific hydroxylation of the Ξ±-carbon of the C-terminal glycine residue. This rate-limiting step requires three essential cofactors: (1) copper ions (two copper atoms per PHM domain), (2) molecular oxygen, and (3) reduced ascorbate as an electron donor
file:COTJA/A0A8C2TBA7/A0A8C2TBA7-uniprot.txt
a [peptide]-C-terminal glycine + 2 L-ascorbate + O2 = a [peptide]-C-terminal (2S)-2-hydroxyglycine + 2 monodehydro-L- ascorbate radical + H2O
Summary: This is the specific molecular function of the PAL domain of PAM, representing the second step of the peptide amidation reaction. The annotation is well-supported by EC number mapping.
Reason: GO:0004598 corresponds to EC 4.3.2.5, which is the precise enzymatic activity of the PAL domain. The UniProt entry explicitly lists this EC number. The PAL domain cleaves the peptidyl-alpha-hydroxyglycine intermediate produced by PHM to generate the alpha-amidated peptide product and glyoxylate. This is a core molecular function of PAM.
Summary: Copper ion binding is essential for PHM catalytic activity. The PHM domain binds two Cu(2+) ions per subunit at conserved histidine and methionine residues. The InterPro-based annotation is well-supported.
Reason: The UniProt entry documents six copper binding residues in the PHM domain (positions 103, 104, 168, 238, 240, 310), all annotated as catalytic copper. The deep research confirms "two copper atoms per PHM domain" are required for the monooxygenase reaction. The InterPro domains IPR000323 and IPR036939 (Cu2_ascorb_mOase) correctly identify this copper-dependent activity. Copper binding is integral to PAM's core catalytic mechanism.
This rate-limiting step requires three essential cofactors: (1) copper ions (two copper atoms per PHM domain), (2) molecular oxygen, and (3) reduced ascorbate as an electron donor
Summary: Extracellular localization is supported by evidence that soluble PAM forms are released into the extracellular space following endoproteolytic processing. The TreeGrafter-based annotation is reasonable.
Reason: PAM exists in both membrane-bound and soluble forms. Soluble PAM forms generated through endoproteolytic processing are secreted into the extracellular space in active form. The deep research confirms "Soluble PAM forms generated through endoproteolytic processing can be secreted into the extracellular space in active form." The TreeGrafter annotation based on PANTHER family assignment is appropriate, as extracellular release of soluble PAM is well-documented across vertebrates. This is a secondary localization rather than the primary site of catalytic activity.
Summary: Peptide metabolic process is a broad biological process term. While technically correct, the more specific term GO:0001519 (peptide amidation) is already annotated and far more informative.
Reason: PAM is indeed involved in peptide metabolism through its role in C-terminal amidation. However, GO:0006518 is a very general parent term that does not convey the specific biological role of PAM. The InterPro-based annotation from IPR000720 (PHM/PAL) is technically correct but redundant with the more specific GO:0001519 (peptide amidation) annotation. Retaining as non-core since it adds no information beyond what the specific term provides.
Summary: PAM is a type I transmembrane protein with a single-pass transmembrane helix. The membrane annotation is correct but very generic. More specific membrane localization (transport vesicle membrane) is already annotated.
Reason: The UniProt entry documents a transmembrane helix at residues 734-758 and PAM is annotated as a single-pass membrane protein. The InterPro-based annotation from IPR000720 correctly identifies PAM as membrane-associated. However, GO:0016020 (membrane) is extremely broad. The more specific term GO:0030658 (transport vesicle membrane) is already annotated and provides better functional context. The primary sites of PAM activity are secretory granule membranes and the trans-Golgi network membrane.
Supporting Evidence:
file:COTJA/A0A8C2TBA7/A0A8C2TBA7-uniprot.txt
Single-pass membrane protein
file:COTJA/A0A8C2TBA7/A0A8C2TBA7-uniprot.txt
TRANSMEM 734..758
GO:0016715 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen
IEA GO_REF:0000002
KEEP AS NON CORE
Summary: This oxidoreductase term accurately describes the chemical mechanism of the PHM domain, which uses ascorbate as an electron donor for copper-dependent hydroxylation. It is a parent term of GO:0004504 (peptidylglycine monooxygenase activity).
Reason: GO:0016715 describes the reaction mechanism of the PHM domain at a chemical level, specifying that it uses reduced ascorbate as a paired donor for oxygen incorporation. This is technically accurate and well-supported by multiple InterPro domains (IPR000323, IPR014783, IPR014784, IPR020611, IPR036939). However, the more specific child term GO:0004504 (peptidylglycine monooxygenase activity) is already annotated and provides substrate-level specificity. Retaining as non-core since the specific term is present and more informative.
This rate-limiting step requires three essential cofactors: (1) copper ions (two copper atoms per PHM domain), (2) molecular oxygen, and (3) reduced ascorbate as an electron donor. One mole of ascorbate is consumed per mole of amidated product formed
file:COTJA/A0A8C2TBA7/A0A8C2TBA7-uniprot.txt
a [peptide]-C-terminal glycine + 2 L-ascorbate + O2 = a [peptide]-C-terminal (2S)-2-hydroxyglycine + 2 monodehydro-L- ascorbate radical + H2O
Summary: PAM localizes to secretory vesicle membranes, which are a type of transport vesicle. The UniProt subcellular location annotation correctly identifies this localization. This is the primary site of PAM catalytic activity.
Reason: The UniProt entry explicitly annotates PAM to "Cytoplasmic vesicle, secretory vesicle membrane" as a single-pass membrane protein. The deep research extensively documents PAM localization to secretory granules and neurosecretory vesicles, where "both PHM and PAL enzymatic activities localize predominantly to neurosecretory vesicle-enriched fractions." PAM is also described as "a major membrane protein of secretory granules" in atrial cardiomyocytes. The GO_REF:0000044 mapping from UniProt subcellular location vocabulary is well-founded. GO:0030658 (transport vesicle membrane) is the appropriate parent term for secretory vesicle membranes in the GO hierarchy.
PAM is packaged into regulated secretory granules and neurosecretory vesicles, where it exists in both membrane-associated and soluble forms. In atrial cardiomyocytes, PAM represents a major membrane protein of secretory granules
both PHM and PAL enzymatic activities localize predominantly to neurosecretory vesicle-enriched fractions
Core Functions
Catalyzing the first step of peptide C-terminal amidation via the PHM domain, which performs copper- and ascorbate-dependent hydroxylation of C-terminal glycine residues on peptide hormone precursors within secretory granules.
The N-terminal PHM domain catalyzes the stereospecific hydroxylation of the Ξ±-carbon of the C-terminal glycine residue. This rate-limiting step requires three essential cofactors: (1) copper ions (two copper atoms per PHM domain), (2) molecular oxygen, and (3) reduced ascorbate as an electron donor
file:COTJA/A0A8C2TBA7/A0A8C2TBA7-uniprot.txt
EC=1.14.17.3
Catalyzing the second step of peptide C-terminal amidation via the PAL domain, which cleaves the peptidyl-alpha-hydroxyglycine intermediate produced by PHM to yield the mature alpha-amidated peptide and glyoxylate.
These computational predictions are reviewed separately from the GOA annotation set used for this review. The assessments below are from this project and do not constitute official GO annotations or endorsement by GO/UniProt. They are not included in the existing annotation review above.
The bifunctional PAM architecture supports PAL catalysis and ascorbate interaction through the PHM module. PAL activity is already annotated; ascorbate binding is an additional supported molecular function.
Prediction method: ProtNLM2 Β· Version: UniProt 2024_06 pilot
Review rationale: The target is assigned to the peptidylglycine alpha-amidating monooxygenase family and contains the PHM/PAL architecture. Structural and substrate-complex experiments on rat PAL establish cleavage of peptidyl-alpha-hydroxyglycine to an amidated peptide and glyoxylate (PMID:19604476), supporting transfer of this conserved reaction to avian PAM. The exact peptidylamidoglycolate lyase activity is already present in cached UniProt and GOA. Domain and reaction evidence support correctness independently of the existing electronic annotation.
Supporting Evidence:
file:COTJA/A0A8C2TBA7/A0A8C2TBA7-uniprot.txt: "ID A0A8C2TBA7_COTJA Unreviewed; 846 AA. ... DR GO; GO:0004598; F:peptidylamidoglycolate lyase activity; IEA:UniProtKB-EC. ... DR InterPro; IPR000323; Cu2_ascorb_mOase_N. ... DR InterPro; IPR024548; Cu2_monoox_C. ... DR InterPro; IPR000720; PHM/PAL. ... FT SIGNAL 1..21 ... FT TRANSMEM 734..758 ... FT DOMAIN 61..172 ... FT /note="Copper type II ascorbate-dependent monooxygenase N- ... FT DOMAIN 197..342 ... FT /note="Copper type II ascorbate-dependent monooxygenase C-"
PMID:19604476: "The structures show that PAL folds as a six-bladed beta-propeller"
Prediction method: ProtNLM2 Β· Version: UniProt 2024_06 pilot
Review rationale: The target contains the conserved PHM copper-monooxygenase module of bifunctional PAM. Pre-steady-state experiments on PHM support ascorbate interaction during reduction and conformational activation (PMID:35380039), providing a biochemical basis for transfer of ascorbate binding to this avian homolog. This concerns the PHM module rather than PAL catalysis and does not specify an unverified binding-site geometry. Ascorbate binding itself is absent from the cached annotations.
Supporting Evidence:
file:COTJA/A0A8C2TBA7/A0A8C2TBA7-uniprot.txt: "ID A0A8C2TBA7_COTJA Unreviewed; 846 AA. ... DR InterPro; IPR000323; Cu2_ascorb_mOase_N. ... DR InterPro; IPR024548; Cu2_monoox_C. ... DR InterPro; IPR000720; PHM/PAL. ... FT SIGNAL 1..21 ... FT TRANSMEM 734..758 ... FT DOMAIN 61..172 ... FT /note="Copper type II ascorbate-dependent monooxygenase N- ... FT DOMAIN 197..342 ... FT /note="Copper type II ascorbate-dependent monooxygenase C-"
PMID:35380039: "ascorbate binds to the enzyme to accomplish reduction"